These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7562509)

  • 1. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
    Takenaka O; Horie T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
    Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
    Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.
    Takenaka O; Horie T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):948-58. PubMed ID: 9023311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide.
    Niinuma K; Takenaka O; Horie T; Kobayashi K; Kato Y; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Aug; 282(2):866-72. PubMed ID: 9262353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat.
    Takikawa H; Sano N; Narita T; Uchida Y; Yamanaka M; Horie T; Mikami T; Tagaya O
    Hepatology; 1991 Aug; 14(2):352-60. PubMed ID: 1860692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
    Nishino A; Kato Y; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
    Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
    Sasabe H; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
    Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
    Ballatori N; Gatmaitan Z; Truong AT
    Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
    Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
    Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
    Sathirakul K; Suzuki H; Yasuda K; Hanano M; Tagaya O; Horie T; Sugiyama Y
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds.
    Shimamura H; Suzuki H; Hanano M; Suzuki A; Tagaya O; Horie T; Sugiyama Y
    J Pharmacol Exp Ther; 1994 Oct; 271(1):370-8. PubMed ID: 7965737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
    Yamazaki M; Kobayashi K; Sugiyama Y
    Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats.
    Lu SC; Cai J; Kuhlenkamp J; Sun WM; Takikawa H; Takenaka O; Horie T; Yi J; Kaplowitz N
    Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.
    Geng W; Schwab AJ; Horie T; Goresky CA; Pang KS
    J Pharmacol Exp Ther; 1998 Feb; 284(2):480-92. PubMed ID: 9454788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic biliary transport after hepatocyte transplantation in Eizai hyperbilirubinemic rats.
    Hamaguchi H; Yamaguchi Y; Goto M; Misumi M; Hisama N; Miyanari N; Mori K; Ogawa M
    Hepatology; 1994 Jul; 20(1 Pt 1):220-4. PubMed ID: 8020892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.
    Sakai H; Suzuki T; Murota M; Oketani K; Uchiumi T; Murakami M; Takeguchi N
    Br J Pharmacol; 2002 Jun; 136(3):383-90. PubMed ID: 12023941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced biliary excretion of lithocholate-3-sulfate by ursodeoxycholate-3,7-disulfate infusion in Eisai hyperbilirubinemic rat (EHBR).
    Takikawa H; Sano N; Ogasawara T; Yamanaka M
    Dig Dis Sci; 1998 Jan; 43(1):188-92. PubMed ID: 9508524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of biliary excretion of lithocholate-3-sulfate in Eisai hyperbilirubinemic rats (EHBR).
    Takikawa H; Nishikawa K; Sano N; Yamanaka M; Horie T
    Dig Dis Sci; 1995 Aug; 40(8):1792-7. PubMed ID: 7648982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.